Investor profile
Rakesh Govindji
As of November 2026, Rakesh Govindji is linked to 2 startups in the Triangle Startups directory. The most recent funding among those companies was Arrivo BioVentures' $45.3 million Series B in November 2023.
Individual investor who has run a private family office in the Triangle since 2015 and, by his own account, backed one Morrisville drug-development team across three companies: seed positions in Neuronex (2011) and Aerial BioPharma (2011) and a Series A position with an advisory board seat at Arrivo BioVentures (2016). Investor and board member at Betr Health (Raleigh) since 2015. Also founder and CEO of Pinnacle Hospitality Partners, a Triangle hotel management and development company, and a limited partner in Frist Cressey Ventures (chair of the LP committee for Funds II and III) and HCG Digital Ventures. These positions are self-reported on his public LinkedIn profile; Arrivo's releases confirm private investors participated in both rounds without naming them.
Directory portfolio
Companies connected here
2
Funding dates unavailable. Companies listed alphabetically.
- A
Arrivo BioVentures
Latest company funding · —
Clinical-stage drug developer with two candidates: forvisirvat (SP-624), a SIRT6 activator in Phase 2b/3 for major depressive disorder, and RABI-767 for predicted severe acute pancreatitis.
- B
Betr Health
Latest company funding · —
Food-as-medicine health coaching platform for gut health, weight, and diabetes
Portfolio coverage reflects public company-investor links tracked in this directory and may not represent the investor's full portfolio.